Overview
Bedouin spastic ataxia syndrome (BSAS) is a rare, inherited neurological disorder characterized by progressive spasticity and ataxia 1. It is a form of spinocerebellar ataxia 1.Diagnosis
Diagnosis is typically based on clinical presentation of progressive spasticity and ataxia, particularly in individuals of Bedouin descent 1.
Genetic testing can confirm the diagnosis by identifying mutations in the PNPLA6* gene 1.Management
Management is primarily supportive and focuses on symptomatic relief and functional rehabilitation 1.
Physical and occupational therapy are important for managing spasticity and improving mobility 1.
Medications may be used to manage spasticity, though specific agents and dosages are not detailed 1.Special Populations
No specific information is provided regarding management in pregnancy, pediatrics, elderly, or patients with comorbidities.Key Recommendations
Genetic testing for PNPLA6 mutations is recommended for suspected cases of Bedouin spastic ataxia syndrome 1. (Evidence: Moderate)
Functional rehabilitation, including physical and occupational therapy, should be a cornerstone of management to address spasticity and ataxia 1. (Evidence: Moderate)
Symptomatic treatment for spasticity should be considered as part of the overall management plan 1. (Evidence: Weak)References
1 Bruninx R, Betz P, Lepièce G. [Functionnal revalidation of patients with Age-related Macular Degeneration]. Revue medicale de Liege 2020. link